Foundation Resource Management Inc Pfizer Inc Transaction History

Foundation Resource Management Inc

$626 Million
Q2 2024

A detailed history of Foundation Resource Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Foundation Resource Management Inc holds 575,672 shares of PFE stock, worth $16.7 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares

575,672

Previous 574,299 0.24%

Holding current value

$16.7 Million

Previous $15.9 Million 1.07%

% of portfolio

2.57%

Previous 2.5%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	BUY	$25.26 - $29.6 $34,681 - $40,640	1,373 Added 0.24%	575,672 $16.1 Million
Q1 2024 Apr 11, 2024	BUY	$25.89 - $29.73 $136,492 - $156,736	5,272 Added 0.93%	574,299 $15.9 Million
Q4 2023 Jan 10, 2024	BUY	$26.13 - $33.94 $2.58 Million - $3.35 Million	98,580 Added 20.95%	569,027 $16.4 Million
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $74,224 - $86,760	-2,313 Reduced 0.49%	470,447 $15.6 Million
Q2 2023 Jul 12, 2023	BUY	$36.12 - $41.79 $2.66 Million - $3.08 Million	73,643 Added 18.45%	472,760 $17.3 Million
Q1 2023 Apr 11, 2023	BUY	$39.39 - $51.28 $59,912 - $77,996	1,521 Added 0.38%	399,117 $16.3 Million
Q4 2022 Jan 12, 2023	SELL	$41.75 - $54.5 $31,479 - $41,093	-754 Reduced 0.19%	397,596 $20.4 Million
Q3 2022 Oct 13, 2022	BUY	$43.76 - $53.42 $149,702 - $182,749	3,421 Added 0.87%	398,350 $17.4 Million
Q2 2022 Jul 15, 2022	SELL	$46.53 - $55.17 $62,210 - $73,762	-1,337 Reduced 0.34%	394,929 $20.7 Million
Q1 2022 Apr 12, 2022	SELL	$45.75 - $56.69 $195,810 - $242,633	-4,280 Reduced 1.07%	396,266 $20.5 Million
Q4 2021 Jan 21, 2022	SELL	$41.32 - $61.25 $16.6 Million - $24.5 Million	-400,546 Reduced 50.0%	400,546 $23.7 Million
Q4 2021 Jan 12, 2022	BUY	$41.32 - $61.25 $16.3 Million - $24.2 Million	394,396 Added 96.98%	801,092 $47.3 Million
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $55,499 - $71,293	-1,414 Reduced 0.35%	406,696 $17.5 Million
Q2 2021 Jul 13, 2021	SELL	$35.91 - $40.68 $319,060 - $361,441	-8,885 Reduced 2.13%	408,110 $16 Million
Q1 2021 Apr 08, 2021	BUY	$33.49 - $37.77 $1.02 Million - $1.16 Million	30,584 Added 7.91%	416,995 $15.1 Million
Q4 2020 Jan 13, 2021	SELL	$33.47 - $42.56 $91,707 - $116,614	-2,740 Reduced 0.7%	386,411 $14.2 Million
Q3 2020 Oct 07, 2020	SELL	$31.75 - $37.25 $362,458 - $425,246	-11,416 Reduced 2.85%	389,151 $14.3 Million
Q2 2020 Jul 08, 2020	SELL	$30.12 - $36.54 $331,952 - $402,707	-11,021 Reduced 2.68%	400,567 $13.1 Million
Q1 2020 Apr 08, 2020	SELL	$27.03 - $38.62 $2.46 Million - $3.52 Million	-91,130 Reduced 18.13%	411,588 $13.4 Million
Q4 2019 Jan 08, 2020	SELL	$32.92 - $37.36 $183,561 - $208,319	-5,576 Reduced 1.1%	502,718 $19.7 Million
Q3 2019 Oct 03, 2019	SELL	$32.49 - $42.13 $234,122 - $303,588	-7,206 Reduced 1.4%	508,294 $18.3 Million
Q2 2019 Jul 10, 2019	SELL	$36.98 - $41.52 $116,191 - $130,455	-3,142 Reduced 0.61%	515,500 $22.3 Million
Q1 2019 Apr 11, 2019	SELL	$37.5 - $41.2 $748,350 - $822,187	-19,956 Reduced 3.71%	518,642 $22 Million
Q4 2018 Jan 17, 2019	SELL	$38.47 - $43.86 $12,310 - $14,035	-320 Reduced 0.06%	538,598 $23.5 Million
Q3 2018 Oct 02, 2018	SELL	$34.47 - $41.81 $7.27 Million - $8.82 Million	-210,923 Reduced 28.13%	538,918 $23.8 Million
Q2 2018 Jul 11, 2018	SELL	$32.98 - $35.16 $148,047 - $157,833	-4,489 Reduced 0.6%	749,841 $27.2 Million
Q1 2018 Apr 19, 2018	SELL	$31.91 - $37.02 $16 Million - $18.6 Million	-502,037 Reduced 39.96%	754,330 $26.8 Million
Q4 2017 Jan 10, 2018	SELL	$33.26 - $35.29 $6 Million - $6.37 Million	-180,501 Reduced 12.56%	1,256,367 $45.5 Million
Q3 2017 Oct 11, 2017	BUY	$31.0 - $34.15 $44.5 Million - $49.1 Million	1,436,868	1,436,868 $51.3 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundation Resource Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foundation Resource Management Inc with notifications on news.

Account

Foundation Resource Management Inc Pfizer Inc Transaction History